Assessment of Admission to the ICU of Onco-hematological Patients.

Launched by UNIVERSITY HOSPITAL A CORUÑA · Nov 1, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how onco-hematological patients—those with blood cancers or solid tumors—are admitted to the Intensive Care Unit (ICU) when they become critically ill. It aims to understand the best ways to care for these patients in a serious health situation. The study will include adults aged 65 to 74, and it is open to anyone with a solid organ tumor or a blood cancer. However, people under 18 years old cannot participate.

Participants in this study will be observed over time as researchers collect information about their health and the care they receive in the ICU. It's important to note that this trial is not yet recruiting participants, so if you or someone you know is interested, it may be worth checking back later for updates. This study could help improve treatment and care for future patients facing similar medical challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults
• • Solid organ tumor or hematological malignancy,
• Exclusion Criteria:
• • -under 18 years old